ClinicalTrials.gg
CompletedNCT00254241Updated Jun 11, 2009

Safety and Efficacy of Seroquel in First Episode Schizophrenia

A Phase 4 interventional study of Seroquel and Risperidone in Schizophrenia, sponsored by AstraZeneca. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2009-06-11.

Sponsored by AstraZeneca · Phase 4, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 70 studies testing quetiapine in Schizophrenia — none open to participants now, none under way, none of them phase 3. quetiapine · Schizophrenia.

Enrollment
40th of 67
80 · median 100
Started
2002
the only one that year
Phase 4
33 of 70
none open now
Registered
20th of 70
by date
Lead sponsor
26 of 70
AstraZeneca

Among the 70 studies testing quetiapine in Schizophrenia, this one is the 40th largest by enrollment of the 67 interventional ones that give a count, is the only one that started in 2002, is one of 33 in phase 4, and was the 20th registered.

Schizophrenia

3,571 studies on the registry are indexed under Schizophrenia; 494 are open to participants now.

Browse Schizophrenia studies →

Open to participants now

None of the 70 studies testing quetiapine in Schizophrenia is open now. The open studies under Schizophrenia, anywhere →

About quetiapine

quetiapine: first FDA approval 1997 (SEROQUEL). What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 333 Schizophrenia studies recruiting now, 63 (19%) set no upper age limit and 258 (77%) stop at 75 or younger; 42 take children under 18; 83 take healthy volunteers.

This study: 18 Years to 35 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 70 studies testing quetiapine in Schizophrenia as a file.
02

Study summary

To compare the safety, tolerability and efficacy of Seroquel and risperidone in first episode schizophrenia

03

Conditions studied

  • Schizophrenia

Browse trials for

Keywords

  • Schizophrenia
04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-35 years Meet ICD-10 criteria for schizophrenia No abnormaility on clinical examination No previous episode of psychosis No previous antipsychotics of any kind in last 3 months

Exclusion criteria

Exclusion Criteria:

  • Have received a course of antipsychotics drug treatment prior to entry which may introduce risk factors or interfere with study procedures Have received anticholinergics within 10 days of baseline aseessment Have received mood stabilizers or anti depressants within 2 weeks
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single
Enrollment
80 participants

Interventions

06

What researchers measure

Primary outcomes

  1. The proportion of patients developing clinically significant EPS at any point between baseline (day 1) and final assessment

Secondary outcomes

  1. CGI severity of illness

  2. CGI global improvement

  3. PANSS total score and subscales)

  4. Abnormal Involuntary Movement Scale (AIMS)

  5. Dose of anti cholinergic medication

  6. Serum prolactin levels

  7. Proportion of patients discontinuing treatment due to reasons of lack of efficacy or adverse effects

  8. Proportion of patients experiencing relapse.

07

Study locations

1 site
  • Research Site
    London, United Kingdom
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of May 2002 and a completion of Jun 2006. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2005
First posted
Nov 16, 2005
Start
May 2002
CompletionActual
Jun 2006
Last update
Jun 11, 2009
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 11, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00254241
Lead sponsor
AstraZeneca
First posted
Nov 16, 2005
Start date
May 2002
Completion
Jun 2006
Last update
Jun 11, 2009

Study contacts

AstraZeneca Seroquel Medical Science Director, MD
study director · AstraZenenca
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Quetiapine · Risperidone

Start the discussion